Understand the source comparison
Does SS-LUP-332 Help Muscle Preservation Research: Mechanism Comparison
SS-LUP-332 (ERRα agonist) Maintains mitochondrial biogenesis and oxidative capacity during energy restriction 18–22% greater lean mass retention vs controls under caloric deficit Increased oxidative metabolism may elevate oxygen consumption; hepatic lipid accu
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- SS-LUP-332 (ERRα agonist)
- Maintains mitochondrial biogenesis and oxidative capacity during energy restriction
- 18–22% greater lean mass retention vs controls under caloric deficit
- Increased oxidative metabolism may elevate oxygen consumption; hepatic lipid accumulation observed in some models
- Preclinical. Rodent models only
- Most promising for metabolic muscle wasting; mechanism addresses root cause rather than symptoms; translation risk high due to species differences in ERRα expression
- HMB (leucine metabolite)
- Inhibits ubiquitin-proteasome pathway; reduces protein breakdown signalling
- 8–12% greater lean mass retention in clinical trials with resistance training
- Minimal at standard doses (3g daily); GI distress in 15% of users
- FDA GRAS status; extensive human data
- Proven but modest effect size; works best when combined with resistance stimulus; doesn't address metabolic root cause
- Myostatin inhibitors
- Block myostatin receptor; remove brake on muscle growth signalling
- 15–30% lean mass gains in genetic knockout models; human antibodies show 3–6% gains
- Muscle hypertrophy without proportional strength gains; tendon stress; potential cardiac effects
- Clinical trials ongoing for muscular dystrophy
- Structural gains don't always translate to function; mechanism bypasses metabolic efficiency entirely
- Ghrelin mimetics (MK-677)
- Stimulates GH/IGF-1 axis; promotes anabolic signalling and appetite
- 2–4% lean mass increase over 12 months; preservation effects unclear
- Insulin resistance risk; significant water retention; appetite stimulation (±15% caloric intake increase)
- Available as research compound; limited controlled trials
- Indirect mechanism through hormone axis; preservation effect confounded by increased food intake
- The comparison underscores SS-LUP-332's unique position: it's the only compound in active muscle preservation research that works by maintaining the metabolic conditions that justify muscle retention rather than blocking breakdown signals or forcing anabolic pathways. That mechanistic novelty is also its greatest clinical uncertainty. No human data exists to confirm the pathway functions identically across species.